Published in
Elsevier, Journal of Clinical Lipidology, 4(15), p. 584-592, 2021
DOI: 10.1016/j.jacl.2021.04.011
Links
Tools
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience
Journal article published in 2021 by
Rodrigo Alonso 
,
Ovidio Muñiz-Grijalvo,
Jose Luis Díaz-Díaz,
Daniel Zambón,
Raimundo de Andrés,
Raquel Arroyo-Olivares,
Francisco Fuentes-Jimenez ,
Juan Sanchez Muñoz-Torrero,
Jose Cepeda,
Rocío Aguado,
Pilar Alvarez-Baños,
Marta Casañas,
Marta Dieguez,
María Dolores Mañas,
Patricia Rubio
and other authors.
,
Ovidio Muñiz-Grijalvo,
Jose Luis Díaz-Díaz,
Daniel Zambón,
Raimundo de Andrés,
Raquel Arroyo-Olivares,
Francisco Fuentes-Jimenez ,
Juan Sanchez Muñoz-Torrero,
Jose Cepeda,
Rocío Aguado,
Pilar Alvarez-Baños,
Marta Casañas,
Marta Dieguez,
María Dolores Mañas,
Patricia Rubio
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 